Sign in
4

Changes in Ownership

BOSTON SCIENTIFIC CORP Filed Acc 0001225208-22-003295

Options or other derivatives

  • EVP Global Chief Med Officer acquired 6,540 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Meredith Ian T · EVP Global Chief Med Officer

Table II: Derivative

1 line
Date Transaction Shares Expires Underlying Owned after D/I
2022-02-22 Grant or award : show line 1 in the form Performance Share Units +6,540 2023-12-31 6,540 6,540 D
Loading xslF345X03/doc4.xml…